Guggenheim analyst Vamil Divan maintained a Buy rating on Pfizer (PFE – Research Report) yesterday. The company’s shares closed yesterday at ...
Pfizer appoints former J&J executive to lead obesity drug development Pfizer on Thursday named James List as the head of the drugmaker's Internal Medicine portfolio, where he will oversee the ...
Influenza causes 140,000 to 710,000 hospitalisations and 12,000 to 52,000 deaths in the US every year, as well as economic losses of around $25 billion a year, according to Pfizer.
After hours: March 12 at 7:59:30 PM EDT Loading Chart for PFE ...
Copyright © 2025 MarketWatch, Inc. All rights reserved.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback
